Jaebeom Cho
Cancer Clinic(US)Chung-Ang University(KR)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer, Hypoxia, and Metabolism, Histone Deacetylase Inhibitors Research, Cancer Cells and Metastasis, RNA modifications and cancer
Most-Cited Works
- → Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells(2015)162 cited
- → The Interplay between Slow-Cycling, Chemoresistant Cancer Cells and Fibroblasts Creates a Proinflammatory Niche for Tumor Progression(2020)48 cited
- → RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse(2021)47 cited
- → Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer(2015)47 cited
- → The ATF6-EGF Pathway Mediates the Awakening of Slow-Cycling Chemoresistant Cells and Tumor Recurrence by Stimulating Tumor Angiogenesis(2020)31 cited
- → Potent Anticancer Effect of the Natural Steroidal Saponin Gracillin Is Produced by Inhibiting Glycolysis and Oxidative Phosphorylation-Mediated Bioenergetics(2020)30 cited
- → Essential Role of DNA Methyltransferase 1–mediated Transcription of Insulin-like Growth Factor 2 in Resistance to Histone Deacetylase Inhibitors(2016)29 cited
- → A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer(2019)28 cited
- → Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly(2022)28 cited
- → S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer(2022)18 cited